story of the week
Recurrence of Severe Symptomatic Late-Onset Neutropenia Related to Ocrelizumab Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab
Mult. Scler. 2023 Oct 27;[EPub Ahead of Print], Y Beigneux, C Louapre, K Bihan, T Roux, R de Paz, C Lubetzki, E MaillartFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.